Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Compound for Vulvar NNEDs
NCT03200808Phase 1Completed
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Oct 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of methylene blue in vulvar nonneoplastic epithelial disorder (VNED), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoint: itching scores at 1 year. Started Oct 2013; status: completed.
02
Drugs
methylene blue
03
Conditions
vulvar nonneoplastic epithelial disorder (VNED)
Beyond the preview
Go deeper on NCT03200808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200808.